You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

~ Buy the NUZYRA (omadacycline tosylate) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR NUZYRA


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for NUZYRA

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03757234 ↗ IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis Completed Paratek Pharmaceuticals Inc Phase 2 2018-11-19 The purpose of this study was to evaluate the safety and efficacy of intravenous (iv) or iv/per oral (po) omadacycline as compared to iv or iv/po levofloxacin in the treatment of female adults with acute pyelonephritis.
NCT04144374 ↗ Omadacycline Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis Completed Paratek Pharmaceuticals Inc Phase 1 2020-02-10 This study will determine the tissue penetration of the novel tetracycline antibiotic, omadacycline (Nuzyra, Paratek Pharmaceuticals, Inc.), into the extracellular, interstitial fluid of soft tissue in diabetic patients with lower limb wound infections. Penetration will be compared with a group of healthy volunteer control participants.
NCT04144374 ↗ Omadacycline Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis Completed Hartford Hospital Phase 1 2020-02-10 This study will determine the tissue penetration of the novel tetracycline antibiotic, omadacycline (Nuzyra, Paratek Pharmaceuticals, Inc.), into the extracellular, interstitial fluid of soft tissue in diabetic patients with lower limb wound infections. Penetration will be compared with a group of healthy volunteer control participants.
NCT04779242 ↗ Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia Recruiting Paratek Pharmaceuticals Inc Phase 3 2021-02-25 The purpose of this study is to evaluate the safety and efficacy of omadacycline as compared to moxifloxacin in the treatment of adults with community-acquired bacterial pneumonia.
NCT04922554 ↗ Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc) Recruiting Paratek Pharmaceuticals Inc Phase 2 2021-10-15 The purpose of this study is to evaluate the efficacy, safety and tolerability of oral omadacycline as compared to placebo in the treatment of adults with Nontuberculous Mycobacterial (NTM) pulmonary disease caused by Mycobacterium abscessus complex (MABc)
NCT05217537 ↗ Study to Evaluate the PK of IV and PO Omadacycline in Children and Adolescents With Suspected or Confirmed Bacterial Infections Not yet recruiting Paratek Pharmaceuticals Inc Phase 1 2022-01-01 The purpose of this study is to evaluate the pharmacokinetics of a single dose of intravenous or oral omadacycline in children and adolescents with suspected or confirmed bacterial infections.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for NUZYRA

Condition Name

Condition Name for NUZYRA
Intervention Trials
Bacterial Pneumonia 1
Community-acquired Pneumonia 1
Diabetes 1
Healthy Volunteers 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for NUZYRA
Intervention Trials
Communicable Diseases 3
Infections 3
Infection 2
Pneumonia, Bacterial 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for NUZYRA

Trials by Country

Trials by Country for NUZYRA
Location Trials
United States 9
Georgia 2
Ukraine 2
Russian Federation 2
Bulgaria 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for NUZYRA
Location Trials
Texas 1
Oregon 1
North Carolina 1
New York 1
New Hampshire 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for NUZYRA

Clinical Trial Phase

Clinical Trial Phase for NUZYRA
Clinical Trial Phase Trials
Phase 3 1
Phase 2 2
Phase 1 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for NUZYRA
Clinical Trial Phase Trials
Recruiting 2
Completed 2
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for NUZYRA

Sponsor Name

Sponsor Name for NUZYRA
Sponsor Trials
Paratek Pharmaceuticals Inc 5
Hartford Hospital 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for NUZYRA
Sponsor Trials
Industry 5
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.